Medicine
Eltrombopag 12.5 mg powder for oral suspension
Eltrombopag 12.5 mg powder for oral suspension is a generic prescription medicine for oral use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature between 20°C to 25°C (68°F to 77°F), excursions…
Key facts
- Active ingredient (INN)
- Eltrombopag
- Brand
- Sold under the generic name
- Strength
- 12.5 mg
- Dosage form
- Powder for oral suspension
- Route
- Oral
- Packs
- 1 carton
- Manufacturer
- Camber PharmaceuticalsIndia
- Origin register
- US FDA, United States
- Storage
- Store at room temperature between 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F). Following reconstitution, the product should be administered immediately but may be stored for a maximum period of 30 minutes between 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- B02BX05 Eltrombopag
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 13 May 2025
- Identifiers
- RxCUI 1859498, 2058980DailyMed set ID 8f6499f0-4774-4f1e-8ab5-145c1fe64401NDC 31722-300Application ANDA216620
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 carton in 1 kit / 30 packet in 1 carton / 1 powder, for suspension in 1 packet | 31722-300-32 | Camber PharmaceuticalsIndia | 13 May 2025 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Eltrombopag 12.5 mg powder for oral suspension.
Other strengths and forms of Eltrombopag
Clinical summary
Eltrombopag is a thrombopoietin receptor agonist indicated for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids. MedsAcross supplies Eltrombopag for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EltrombopagFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- PROMACTA prescribing information (Novartis Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Revolade: European public assessment report (EPAR) · European Medicines Agency
- Eltrombopag Accord: European public assessment report (EPAR) · European Medicines Agency
Need Eltrombopag 12.5 mg powder for oral suspension for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.